Waters Corporation

WAT Healthcare Diagnostics & Research

Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

436.95 7.20 −1.62%
Market cap
$43.6B
P/E
109×
Fwd P/E
44.3×
Dividend yield
—
F-score
5/9
Altman Z
9.63
Beneish M
−2.37
Dividend safety
n/a

Waters Corporation (WAT) Total debt

Alert me on Total debt

Waters Corporation's total debt at the end of fiscal 2025 was $947.4M, down 41.7% from $1.6B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $4.9B. Over the past ten years it has ranged from $947.4M (fiscal 2025) to $2.3B (fiscal 2023) — the current reading is the lowest in ten years. Waters Corporation ranks 6th of 50 Diagnostics & Research companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $947.4M (41.75%)
FY2024 $1.6B (29.45%)
FY2023 $2.3B 51.19%
FY2022 $1.5B 0.73%
FY2021 $1.5B 25.47%
FY2020 $1.2B (23.68%)
FY2019 $1.6B 37.68%
FY2018 $1.1B (39.49%)
FY2017 $1.9B 11.49%
FY2016 $1.7B 13.99%

Quarterly newest first

Period Total debt Change
Jun 2026 $4.9B 0.64%
Mar 2026 $4.9B 412.67%
Dec 2025 $947.0M (0.02%)
Sep 2025 $947.2M (20.87%)
42 more quarters

Against its own ten years

Low $947.4M High $2.3B
Ten-year median $1.5B
Current reading's percentile 9

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on WAT